Norway tests PDT (Photodynamic therapy) for brain tumours
This article was originally published in Clinica
Photodynamic therapy (PDT) has been used for the first time in Norway to halt the growth of brain tumours. The procedure has been carried out on 14 patients with glioblastoma so far, says the Norwegian state hospital (Rikshospitalet). The operations have been supported by the Norwegian cancer society.
You may also be interested in...
Stephen Hahn’s low visibility period as the newly installed FDA commissioner comes to an abrupt end. Trump offers generous praise amid COVID-19 response – but how quickly might that change to blame?
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.